AMS Joins Avensys: Strengthening Decontamination and Biomedical Engineering Support Across UK Healthcare
The demands placed on healthcare providers continue to increase, with patient safety, infection prevention, and respiratory regulatory compliance at the forefront of clinical priorities. Medical equipment and decontamination processes must perform reliably every day, supported by partners who understand both the technical and governance requirements of modern hospitals.
As part of this ongoing commitment to quality and innovation, AMS (Audere Medical Services) has joined Avensys and will now operate as Avensys Decontamination. This change reflects more than a name update; it represents a strategic alignment that brings specialist decontamination expertise into the wider Avensys biomedical engineering group, creating a stronger, more integrated service offering for NHS trusts and private healthcare providers across the UK.
Why this development matters
Decontamination and medical device management are critical components of safe healthcare delivery. Sterile Services Departments, operating theatres, and clinical environments rely on decontamination equipment that is correctly maintained, validated, and supported in line with national guidance such as HTM 01-01. Any disruption to these systems can increase risk, place additional pressure on clinical teams, and impact patient care.
Healthcare organisations increasingly require partners who can deliver reliable technical support while also helping them demonstrate compliance, maintain accurate records, and remain audit-ready. The introduction of Avensys Decontamination strengthens the ability to meet these expectations through a joined-up, quality-led service model.
From AMS to Avensys Decontamination
Formerly known as Audere Medical Services (AMS), Avensys Decontamination is a UK-based specialist provider of medical decontamination services with more than twenty-four years of experience in the sector. The transition to Avensys Decontamination ensures continuity for existing customers while creating opportunities for service expansion, investment, and closer collaboration with biomedical engineering teams. Avensys Decontamination will still support a wide range of healthcare environments, including NHS hospitals, private hospitals, dental practices, laboratories, and academic institutions.
Avensys Decontamination specialises in the servicing, validation, and repair of decontamination equipment in line with HTM 01-01 through HTM 01-06, The organisation’s established focus on reliability, traceability, and detailed documentation remains central to its approach. helping healthcare providers maintain safe and effective infection prevention processes. AMS is known for its focus on reliability, traceability, and detailed documentation, which plays a vital role in supporting compliance and performance monitoring.
With access to Avensys’s national infrastructure and systems, Avensys Decontamination is well positioned to deliver consistent, responsive support across single and multi-site healthcare environments.
Who are Avensys?
Avensys is one of the UK’s leading independent biomedical engineering organisations, providing medical equipment services to NHS and private healthcare providers nationwide. The company supports the full lifecycle of medical devices, from maintenance and repair to training and equipment management.
Avensys operates to internationally recognised quality and environmental standards, reinforcing its commitment to safety, compliance, and continuous improvement. With a strong national engineering presence, Avensys supports healthcare providers across multiple clinical settings, ensuring medical devices remain reliable, compliant, and fit for purpose.
The organisation’s focus on partnership, flexibility, and technical excellence has made it a trusted supplier across the healthcare sector.
The addition of Avensys Decontamination further strengthens Avensys’s ability to deliver joined-up technical services across clinical, sterile services, and infection prevention infrastructure.
Why Avensys Decontamination strengthens the Avensys group
The integration of decontamination expertise into Avensys creates a more complete technical service offering for healthcare providers. Decontamination services and biomedical engineering are closely connected in practice, yet they are often delivered under separate contracts and managed independently. This move brings those disciplines closer together, enabling a more coordinated approach to equipment support and compliance.
For healthcare customers, this translates into simpler service management, clearer accountability, and improved consistency across sites. Technical issues can be addressed more efficiently, supported by shared systems, processes, and engineering expertise.
Avensys Decontamination contributes deep specialist knowledge in decontamination and validation, while Avensys contributes national scale, infrastructure, and established quality frameworks. Together, this combination enhances service capacity, improves response times, and provides greater resilience, particularly for organisations operating across multiple locations.
Strengthening compliance and patient safety
Decontamination services are not solely about keeping equipment operational; they are fundamental to protecting patients and staff. Validation, testing, and accurate record-keeping provide assurance that decontamination processes are working as intended and in line with recognised guidance such as HTM 01-01.
Avensys Decontamination’s experience in producing detailed, compliant documentation aligns closely with Avensys’s quality-led approach to biomedical engineering. The combined organisation is therefore well placed to support healthcare providers with audit readiness, governance requirements, and long-term compliance strategies.
This shared commitment reinforces both organisations’ focus on patient safety and infection prevention as core principles, not optional extras.
Growth, continuity, and future development
Becoming Avensys Decontamination allows the former AMS team to retain its specialist identity while benefiting from the stability and resources of a larger organisation. This supports continued investment in people, training, and service innovation, ensuring customers receive consistent, high-quality support both now and in the future.
For engineers and technical staff, the integration creates broader development opportunities within the Avensys group while maintaining a clear focus on decontamination excellence.
Strategic advantages for Avensys
For Avensys, the addition of Avensys Decontamination strengthens its presence in a critical area of healthcare infrastructure. Decontamination and sterile services are essential to safe clinical practice, and expanding capability in this area supports Avensys’s ambition to deliver end-to-end technical solutions.
This move also reinforces Avensys’s role as a long-term partner to healthcare providers, capable of supporting complex technical and compliance requirements across multiple disciplines.
What this means for healthcare providers
For existing and new customers, Avensys Decontamination offers a more joined-up approach to technical services. Healthcare providers benefit from improved coordination between decontamination support and wider biomedical engineering services, helping reduce downtime, improve consistency, and manage risk more effectively.
The combined Avensys group is better positioned to support evolving healthcare demands, offering scalable services that adapt to changes in regulation, technology, and service delivery models.
Looking ahead
The introduction of Avensys Decontamination marks an important milestone in the evolution of both organisations. By bringing specialist decontamination expertise into the Avensys biomedical engineering group, this integration strengthens technical capability, supports patient safety, and enhances service delivery across UK healthcare.
To learn more about Avensys Decontamination and how the expanded Avensys service offering can support your organisation, contact the Avensys team today.